Does Healthcare Invest Enough in Keeping People Healthy?

Modern medicine is extraordinary.

Conditions that once had few effective treatments can now be managed successfully. Surgical techniques continue to improve. Diagnostic technology is becoming more sophisticated, and pharmaceutical research has produced therapies that have transformed countless lives.

But healthcare still faces an interesting imbalance.

We spend enormous amounts treating disease once it develops.

What would happen if we became equally ambitious about keeping people healthier before that point?

Treatment and Prevention Aren’t Competitors

It’s easy for discussions about preventative healthcare to become unnecessarily adversarial.

Medicine versus lifestyle.

Pharmaceuticals versus nutrition.

Treatment versus prevention.

That’s not a particularly helpful way of thinking about health.

People need medicine.

People also benefit from appropriate preventative care.

The strongest healthcare system should be capable of doing both.

If somebody develops a serious condition, we want the best treatment available.

At the same time, where evidence supports it, we should also make it easier for people to address modifiable risk factors earlier.

Why Treatment Attracts Investment

Developing a new medicine can create a clearly defined product.

If successful, intellectual property can protect the innovation and allow the company to recover the substantial cost of research and clinical development.

That commercial model helps fund medical innovation.

Prevention can be very different.

Improving sleep doesn’t belong to one company.

Exercise isn’t patented.

General healthy eating principles aren’t proprietary.

Helping someone consistently change their behaviour may require ongoing professional support rather than a single product.

As a result, preventative healthcare can have a different economic model even when the potential long-term benefit is significant.

Research Funding Matters

Medical research doesn’t happen simply because somebody has an interesting question.

Studies cost money.

Large clinical trials can be particularly expensive.

Researchers therefore need governments, universities, foundations or private organisations willing to finance the work.

Those funding decisions influence the questions that get answered.

Some areas attract enormous resources.

Others receive comparatively little attention.

This doesn’t necessarily mean anybody is deliberately ignoring useful ideas.

It means healthcare research operates within economic constraints.

Understanding those constraints helps us have a more constructive conversation about improving the system.

Prevention Needs Evidence Too

There’s also an important point that sometimes gets lost.

Something being natural, inexpensive or impossible to patent does not automatically mean it works.

Preventative healthcare still needs evidence.

Supplements can be ineffective or harmful.

Extreme diets can create problems.

Health claims spread rapidly online without appropriate clinical support.

The answer to concerns about pharmaceutical incentives isn’t lowering scientific standards.

It’s making sure good research can also investigate important questions where commercial incentives may be weaker.

Technology Could Help Close the Gap

Digital healthcare may make preventative care easier to deliver.

Patients can complete assessments remotely.

Relevant health information can be organised over time.

Clinicians can follow changes rather than seeing only isolated snapshots.

Reminders and follow-up can improve engagement.

AI may eventually help clinicians navigate increasingly complex health information.

None of this replaces professional care.

It can simply make ongoing participation more practical.

That’s one of the opportunities we’re exploring at Castill Health.

Keeping People Engaged Matters

Prevention doesn’t usually happen through one dramatic intervention.

It’s often the result of ordinary decisions repeated over long periods.

Attending recommended screening.

Managing blood pressure.

Addressing smoking.

Improving nutrition.

Increasing physical activity.

Seeking medical advice when something changes.

The challenge isn’t only knowing that these things matter.

It’s helping people remain engaged with them.

Healthcare technology can potentially make that easier.

Looking Ahead

Pharmaceutical innovation will remain essential.

So will hospitals, doctors, surgery and specialist medicine.

But prevention deserves ambition too.

We should continue asking how healthcare can identify relevant risks earlier, help people participate more actively in their health and make evidence-based preventative care easier to access.

The goal isn’t replacing treatment.

It’s reducing the number of times treatment becomes necessary where that can reasonably be achieved.

Because one of the most valuable outcomes healthcare can deliver isn’t simply helping someone recover from illness.

It’s helping them remain well in the first place.